Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
177
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchmed China Ltd
•
19 Jun 2021 17:09
HutchMed Secondary Listing: HK-ADS Premium/(Discount) Views
HutchMed has launched a $603 million secondary listing on HKEx. In this note, we will look at HutchMed’s potential HK-ADS premium/(discount).
Arun George
Follow
312 Views
Share
bullish
•
Hutchmed China Ltd
•
18 Jun 2021 16:08
HCM Secondary Listing: Not a Good Performer
After its failed listing attempt 2019, today HCM launched its book building to raise USD 590m in its secondary listing in Hong Kong. We look at...
Ke Yan, CFA, FRM
Follow
403 Views
Share
bearish
•
Link REIT
•
19 Apr 2021 05:59
Link REIT – Cash Burning Holes
LINK REIT: Negative rental reversion rates and tenant sales persist in Hong Kong, negative revaluation of property continues. Link is hellbent on...
Thomas J. Monaco
230 Views
Share
bearish
•
Link REIT
•
25 Feb 2021 05:36
Link REIT – Same Old, Same Old
LINK REIT: Link is acquiring a 50% stake in Qibao Vanke Plaza (QVP) in China. Its unclear if the numbers make sense given the variables, the lack...
Thomas J. Monaco
217 Views
Share
bearish
•
Link REIT
•
10 Nov 2020 07:55
Link REIT – Bread and Butter Melting
LINK REIT: Almost Nothing Is Going Right For Link REIT. Rental Reversion Rates Weakening In Hong Kong; FV Marks Remain Negative; and Capital...
Thomas J. Monaco
214 Views
Share
First
Previous
9
10
11
12
13
14
15
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x